A unified deep-learning framework for enhanced patient-specific quality assurance of intensity-modulated radiation therapy plans.

backgroundModern radiation therapy techniques, such as intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT), use complex fluence modulation strategies to achieve optimal patient dose distribution. Ensuring their accuracy necessitates rigorous patient-specific quality assurance (PSQA), traditionally done through pretreatment measurements with detector arrays. While effective, these methods are labor-intensive and time-consuming. Independent calculation-based methods leveraging advanced dose algorithms provide a reduced workload but cannot account for machine performance during delivery. PURPOSE: This study introduces a novel unified deep-learning (DL) framework to enhance PSQA. The framework can combine the strengths of measurement- and calculation-based approaches.

methodsA comprehensive artificial training dataset, comprising 400,000 samples, was generated based on a rigorous mathematical model that describes the physical processes of radiation transport and interaction within both the medium and detector. This artificial data was used to pretrain the DL models, which were subsequently fine-tuned with a measured dataset of 400 IMRT segments to capture the machine-specific characteristics. Additional measurements of five IMRT plans were used as the unseen test dataset. Within the unified framework, a forward prediction model uses plan parameters to predict the measured dose distributions, while the backward prediction model reconstructs these parameters from actual measurements. The former enables a detailed control point (CP)-wise analysis. At the same time, the latter facilitates the reconstruction of treatment plans from the measurements and, subsequently, dose recalculation in the treatment planning system (TPS), as well as an independent second check software (VERIQA). This method has been tested with an OD 1600 SRS and an OD 1500 detector array with distinct spatial resolution and detector arrangement in combination with a dedicated upsampling model for the latter.

resultsThe final models could deliver highly accurate predictions of the measurements in the forward direction and the actual delivered plan parameters in the backward direction. In the forward direction, the test plans reached median gamma passing rates better than 94% for the OD 1600 SRS measurements. The upsampled OD 1500 measurements show similar performance with similar median gamma passing rates but a slightly higher variability. The 3D gamma passing rates from the comparisons between the original and reconstructed dose distributions in patients lie between 95.4% and 98.2% for the OD 1600 SRS and 94.7% and 98.5% for the interpolated OD 1500 measurements. The dose volume histograms (DVH) of the original and the reconstructed plans, recalculated in both the TPS and VERIQA, were evaluated for the organs at risk and targets based on clinical protocols and showed no clinically relevant deviations.

conclusionsThe flexibility of the implemented model architecture allows its adaptability to other delivery techniques and measurement modalities. Its utilization also reduces the requirements of the measurement devices. The proposed unified framework could play a decisive role in automating QA workflow, especially in the context of real-time adaptive radiation therapy (ART).